PGNY · ISSUER CIK 1551306
Progyny, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 6 Progyny, Inc. insiders reported $0.00 of open-market purchases and $476K of sales on SEC Form 4.
↗6 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 2 of 3 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$476KInsider selling
−$476KNet open-market
Oct 16, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 202616:56 | Oct 14, 2026 | PGNY | Chief Operating Officer | S · Sell10b5-1 | $28.00 | −1,879 | 66,496 | -3% | −$53K | ||
| Oct 16, 202616:56 | Oct 14, 2026 | PGNY | Chief Operating Officer | F · Tax10b5-1 | $27.39 | −1,559 | 68,375 | -2% | $43K | ||
| Sep 28, 202616:30 | Sep 23, 2026 | PGNY | EVP, GC | S · Sell10b5-1Late 5d | $26.10 | −3,903 | 75,816 | -5% | −$102K | ||
| Sep 21, 202617:20 | Sep 17, 2026 | PGNY | Chief Product Officer | F · Tax | $27.38 | −819 | 59,009 | -1% | $22K | ||
| Sep 14, 202617:53 | Sep 10, 2026 | PGNY | Director | S · Sell | $27.94 | −11,500 | 6,792 | -63% | −$321K | ||
| Sep 14, 202617:53 | Sep 10, 2026 | PGNY | Director | M · Exercise | $13.00 | +22,000 | 28,792 | +324% | $286K | ||
| Sep 14, 202617:53 | Sep 10, 2026 | PGNY | Director | F · Tax | $27.24 | −10,500 | 18,292 | -36% | $286K | ||
| Sep 8, 202616:19 | Sep 3, 2026 | PGNY | CHIEF EXECUTIVE OFFICER, Director | F · TaxLate 5d | $26.29 | −5,361 | 806,111 | -1% | $141K | ||
| Sep 8, 202616:18 | Sep 4, 2026from Sep 3, 2026 | PGNY | EVP, GC | F · Tax | $26.41 | −1,307 | 79,719 | -2% | $35K | ||
| Sep 8, 202616:17 | Sep 4, 2026 | PGNY | CHIEF FINANCIAL OFFICER | F · Tax | $26.61 | −479 | 72,453 | -1% | $13K | ||
| Sep 4, 202616:28 | Sep 3, 2026from Sep 2, 2026 | PGNY | CHIEF FINANCIAL OFFICER | F · Tax | $26.21 | −1,756 | 72,932 | -2% | $46K | ||
| Sep 1, 202616:38 | Aug 28, 2026 | PGNY | EVP, GC | F · Tax | $25.86 | −1,352 | 81,026 | -2% | $35K |